Skip to main content
Premium Trial:

Request an Annual Quote

IBM Joins SNP Consortium, Second Tech Co. Member

Premium

C

hicago--The SNP Consortium announced that IBM has joined its group effort to create a public database of gene markers to enhance understanding of the biological basis for disease. IBM joins 10 major pharmaceutical companies, the Wellcome Trust, and Motorola in the two-year, $50 million initiative to identify and analyze SNPs.

Founded last year, the consortium intends to identify a minimum of 300,000 and map at least 150,000 SNPs by April 2001. Since November, the group has deposited some 7,200 newly identified and characterized SNPs into public databases accessible through the internet, said the consortium.

Filed under

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.